coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Healthy Horley PCN, Reigate and Banstead · Health Inequalities Profile

    PCN U84550 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 2 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    45,192

    Registered population

    59.8% aged 18–64

    19.1%

    Aged 65+

    ICB 18.8% · England 17.9%

    15.8%

    Ethnic minority (non-White)

    7.1% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    6,625

    Hypertension register

    +12.63% in 3 yrs · England +5.60%

    421

    SMI register

    36.5% of Reigate and Banstead's

    643

    COPD register

    Reviews +10.45% in 3 yrs

    Forecast to 2030

    9,226

    Hypertension patients, 2030

    +2,601 on today

    57.0%

    QRISK ≥20% on statins, 2030

    +2.24pp over 3 yrs

    6.2%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    52.2%
    CVD lipid therapy and blood pressure control lag.

    QRISK ≥ 20% lipid therapy is 52.2% (England 63.6%) and hypertension control is 67.4% (England 70.3%) despite 90.6% blood pressure recording.

    -12.2%
    COPD and asthma registers contracted over three years.

    From 2023 to 2025, QOF prevalence changed -12.2% for COPD (England +2.6%) and -5.8% for asthma (England +0.5%), which a coding audit could test.

    +25.5 pp
    SMI physical health checks and borough inclusion share.

    Mental health blood pressure recording rose +25.5 pp to 87.2% (England 83.4%), alongside 49% of the borough learning disability register (397 patients).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older patients reach 19.1% while learning disability prevalence of 0.9% exceeds England

    Healthy Horley PCN registers 45,192 patients. Those aged 65+ represent 19.1% (8,616 patients), against 19.4% in Reigate and Banstead, 18.8% in NHS Surrey Heartlands ICB, and 17.9% in England. Patients aged 0-17 account for 21.2% (9,561 patients; LAD 21.0%, ICB 20.4%, England 19.6%). Based on Census usual residents, 84.2% identify as White (LAD 84.4%, ICB 85.3%, England 81.1%) and 7.1% as Asian (LAD 7.5%, ICB 7.7%, England 9.6%). Projected population growth to 2030 is 7.4% under an unverified methodology (LAD 3.2%, ICB 4.9%, England 2.3%). Practice list sizes total 52,403 against the PCN list of 45,192.

    Age profile

    0–1721.2%
    18–6459.8%
    65+19.1%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White84.2%
    Asian7.1%
    Mixed4.0%
    Black3.4%
    Other1.3%

    Older people · falls rows are Reigate and Banstead local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Reigate and Banstead LA)2,1542,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)86.5%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)57.5%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Reigate and Banstead LA)9919819552024/25
    Falls deaths, all ages, per 100,000 (Reigate and Banstead LA)8.914.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Zero registered patients live in Core20 areas; equity work could target inclusion cohorts

    Healthy Horley PCN records 0.0% of its 45,192 registered patients in Core20 areas (0 estimated patients). Practice lists total 52,403, yet Modality East Surrey Medical Practice and Wayside Medical Practice both record 0.0% Core20 share, compared with 1.1% in Reigate and Banstead, 0.8% in NHS Surrey Heartlands Integrated Care Board, and 21.0% in England. Average IMD decile is 7.0 (both practices 7.1), above England's 5.5. With zero Core20 concentration and count, inequalities outreach could target inclusion health and clinical cohorts rather than area postcodes.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Wayside Medical0.0% · 0 patients
    Modality East0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    421

    SMI register

    0.93% recorded prevalence

    397

    Learning disability register

    0.88% recorded prevalence

    38

    Care homes, 809 beds

    In the PCN catchment

    7.9%

    Provide unpaid care

    Reigate and Banstead, Census 2021

    The PCN records 397 learning disability patients (0.9% prevalence vs 0.6% LAD and England, 0.5% ICB), representing 49% of the borough register, alongside 421 severe mental illness patients (0.9% vs 0.8% LAD and ICB, 1.0% England). Catchment capacity shows 38 care homes with 809 beds. Reigate and Banstead recorded 6 rough sleepers in 2025, with an unpaid carer ceiling estimate of 3,570.

    Severe mental illness: physical health checks

    SMI prevalence is 0.9% (421 patients). Recorded checks exceed England: blood pressure reached 87.2% (England 83.4%) and BMI reached 84.7% (England 82.1%). However, separate indicator reporting does not confirm comprehensive physical health check completion across the cohort.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,625

    Hypertension register

    +12.63%

    Register growth, 3 yrs

    Reigate and Banstead +4.55% · England +5.60%

    +4.56pp

    BP control, under 80

    ≤140/90 · −0.22pp aged 80+

    +2,601

    More patients by 2030

    Forecast 9,226 (18.53%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 14.6% (6,625 patients), close to Reigate and Banstead (14.0%) and England (15.2%). Recent blood pressure recording reaches 90.6%, above England (90.0%). However, treatment to target trails at 67.4% (England 70.3%, borough 72.0%), including 64.2% in patients aged under 80 (England 67.8%) and 74.8% aged 80+ (England 81.2%), where 3-year change fell 0.3% (England +2.2%). Between practices, treatment to target varies from 52.1% at Wayside Medical Practice to 69.2% at Modality East Surrey Medical Practice. Lower treatment to target than national benchmarks may reflect therapy escalation gaps across practices, which a clinical audit could test.

    Lipids and statins

    Lipid-lowering therapy uptake lags England across priority cohorts: QRISK ≥ 20% reaches 52.2% (England 63.6%), CKD is 57.0% (England 70.3%), and diabetes with CVD is 77.1% (England 84.4%). Fewer patients receive lipid-lowering therapy than national rates, which systematic statin initiation reviews could address.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202648,345£1.90£2.24£1.86£91,856
    Cardiovascular (all), 202577,521£4.46£4.74£3.33£345,744

    In 2026, 48,345 lipid-regulating items were prescribed at £1.90 per item (England £1.86, ICB £2.24), totaling £91,856. The PCN spends £1,934 more than at England's unit cost, but £16,437 less than at NHS Surrey Heartlands Integrated Care Board's unit cost. Prescribing unit costs below the ICB benchmark offer headroom to expand statin therapy.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +8.98%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −5.79%

    Asthma prevalence, PCN 3-yr % change

    Over three years, COPD prevalence fell 12.2% (England +2.6%; 643 patients, 1.4% vs England 1.9%) and asthma fell 5.8% (England +0.5%; 2,696 patients, 6.3%). Register contraction may reflect coding changes or diagnostic access patterns, which local clinical audits could test. Although the asthma review rate was 69.5% (England 65.7%), about 820 patients lacked an annual review. In youth asthma (aged 6-19), second-hand smoke status recording reached 69.8%, below England (78.8%) and Reigate and Banstead (79.7%).

    Cancer register and children's immunisation

    The cancer register grew +16.4% over three years (England +9.0%) to 2,080 patients (4.6% vs England 3.8%). In childhood immunisations, age-five MMR dose 1 reached 95.5% (England 91.7%), but dose 2 dropped 4.6 pp to 90.9% (England 82.8%), matching 4-in-1 pre-school booster coverage (90.9%). While above national rates, both age-five boosters trail the 95.0% target by 4.1 pp, highlighting pre-school recall drop-off.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.5%

    England 91.0%

    6-in-1 complete primary course at 24 months95.7%

    England 92.2%

    MMR dose 1 at 24 months92.3%

    England 88.3%

    MMR dose 2 at age 590.9%

    England 82.8%

    4-in-1 pre-school booster at age 590.9%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    Across Healthy Horley PCN, recorded cancer prevalence is 4.6% (2,080 patients), rising 16.4% over three years (England +9.0%). Breast screening coverage is 68.5% (Reigate and Banstead 74.6%, England 69.9%) after a three-year rise of 10.3%. Cervical screening in women aged 25–49 is 71.9% (England 66.8%), falling 2.7% over three years (England -1.0%). Across the wider health economy, NHS Surrey Heartlands ICB diagnosed 61.4% of known-stage cancers at stage 1 or 2 in 2022 (known-stage share 67.7%), 13.6 pp below the 75.0% national ambition, representing about 650 extra early-stage cases annually.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At the main acute provider serving the PCN, Surrey and Sussex Healthcare NHS Trust, July 2026 provisional performance achieved 70.0% on the 62-day referral to treatment standard, trailing the 85.0% standard by 15.0 pp and below England at 71.2%. The trust achieved 77.7% on the 28-day faster diagnosis standard (standard 75.0%) and 96.2% on the 31-day combined standard (standard 96.0%). For diagnostics, 28.5% of patients waited 6+ weeks across all diagnostic tests, exceeding England's 23.1%. These figures reflect hospital provider activity rather than direct PCN delivery. Prolonged treatment and diagnostic pathways at the acute provider may increase primary care safety-netting.

    Pathways within standard (%)Surrey and Sussex HealthcareSussexEpsom and St HelierSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)77.7474.0189.7079.2979.32
    31-day treatment (96%)96.2076.7999.1690.4592.50
    62-day referral to treatment (85%)69.9765.2086.8271.5171.16
    Diagnostic waits over 6 weeks (%)Surrey and Sussex HealthcareSussexEpsom and St HelierEngland
    MRI27.535.620.3121.40
    CT18.498.571.069.92
    Echocardiography43.780.3925.4928.48
    Colonoscopy15.1139.3533.0130.83
    Gastroscopy21.0620.0230.9029.02
    All 15 DM01 tests28.5012.956.8323.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In June 2026 provisional experimental data, Surrey residents accounted for 109,530 community care contacts, 66,060 care activities, 33,510 patients with a contact, and 28,700 referrals. Across NHS Surrey and Sussex ICB, contacts totaled 309,615. Adults aged 65+ accounted for 69.6% of borough residents' contacts. These figures capture provider-submitted community activity across local authority residents, not PCN-specific cohorts.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Vaccination achievement spans 9.4 percentage points across practices alongside varying personalised care adjustments

    In 2025/26, overall QOF achievement was 93.2% at Modality East Surrey Medical Practice and 84.1% at Wayside Medical Practice (England 92.5%). Vaccination and immunisation achievement trailed England (55.2%) at both sites, reaching 44.5% at Modality East Surrey Medical Practice and 35.1% at Wayside Medical Practice, spanning a 9.4 pp range. This gap could reflect call-and-recall differences, which an audit could.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Wayside Medical850.058.3%77.3%81.3%
    Modality East950.063.1%86.3%75.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNReigate and BansteadAssetPCNReigate and Banstead
    Care homes (catchment)38 (809 beds)n/aSchools (catchment)64n/a
    Children's centres48Places of worship4270
    Libraries36Food banks (VCS)56
    Homelessness support (VCS)22Day centres (VCS)840
    Children and young people (VCS)38Carers support groups (VCS)16
    Primary schools (LA maintained)1214Primary academies818

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension titration and statin escalation

    Hypertension treatment to target is 67.4% across 6,625 patients (England 70.3%, Reigate and Banstead 72.0%), and QRISK ≥ 20% lipid therapy is 52.2% (England 63.6%). For discussion: run pharmacist-led medication titration and statin initiation recalls for patients above blood pressure thresholds or with untreated QRISK ≥ 20%. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Asthma annual review and youth recall

    Asthma reviews cover 69.5% of the 2,696 register (leaving 822 unreviewed), while youth second-hand smoke recording is 69.8% (England 78.8%, Reigate and Banstead 79.7%). For discussion: introduce a standardised asthma review recall template with mandatory youth second-hand smoke prompts and after-school appointment slots. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    COPD register validation and case-finding

    COPD prevalence is 1.4% (643 patients), matching Reigate and Banstead (1.4%) but 0.5 pp below England (1.9%), with a benchmark gap range of -28 to +213. For discussion: search for smokers and ex-smokers on repeat respiratory prescribing without a COPD code, and raise diagnostic spirometry capacity with system partners. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Inclusion health equity targeting (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Blood pressure titration audit (p5)Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall outreach (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Screening recall and outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Hypertension titration and statin escalation (p12)Hypertension register · Hypertension patients with a recent BP reading · Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 2 · Asthma annual review and youth recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · COPD register validation and case-finding (p12)COPD register · COPD: QOF prevalence · Registered populationCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15